Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis.
Eguchi
Katsumi
K
D001327:Autoimmune Diseases / Q000150:complications* / Q000188:drug therapy; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D003092:Colitis / Q000150:complications*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D016207:Cytokines / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000150:complications*; D004198:Disease Susceptibility; D005260:Female; D015616:Histiocytosis, Non-Langerhans-Cell / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use
D016207:Cytokines; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine